Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100

This publication has 63 references indexed in Scilit:

• Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization
  Blood, 2009
• Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model
  Haematologica, 2008
• AMD3100 synergizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout mice
  Experimental Hematology, 2008
• CXCR4 is required for the quiescence of primitive hematopoietic cells
  The Journal of Experimental Medicine, 2008
• Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia
  Blood, 2007
• Hematopoietic Progenitor Cells (HPC) from Mobilized Peripheral Blood Display Enhanced Migration and Marrow Homing Compared to Steady-State Bone Marrow HPC
  Experimental Hematology, 2007
• Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
  Blood, 2003
• Collection of hematopoietic stem cells from patients with autoimmune diseases
  Bone Marrow Transplantation, 2001
• Donating stimulated peripheral blood stem cells vs bone marrow: do donors experience the procedures differently?
  Bone Marrow Transplantation, 2001
• Impaired Production and Increased Apoptosis of Neutrophils in Granulocyte Colony-Stimulating Factor Receptor–Deficient Mice
  Immunity, 1996